AAAAAA
Results:
1-19
|
Results: 19
Authors:
Suen, TC
Goss, PE
Citation: Tc. Suen et Pe. Goss, Identification of a novel transcriptional repressor element located in thefirst intron of the human BRCA1 gene, ONCOGENE, 20(4), 2001, pp. 440-450
Authors:
Goss, PE
Strasser, K
Citation: Pe. Goss et K. Strasser, Aromatase inhibitors in the treatment and prevention of breast cancer, J CL ONCOL, 19(3), 2001, pp. 881-894
Authors:
Goss, PE
Citation: Pe. Goss, Chemoprevention with aromatase inhibitors, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 161-181
Authors:
Cohen, L
Hack, TF
de Moor, C
Katz, J
Goss, PE
Citation: L. Cohen et al., The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment, ANN SURG O, 7(6), 2000, pp. 427-434
Authors:
Goss, PE
Strasser, K
Marques, R
Clemons, M
Oza, A
Goel, R
Blackstein, M
Kaizer, L
Sterns, EE
Nabholtz, JM
De Coster, R
Crump, M
Abdolell, M
Qi, S
Citation: Pe. Goss et al., Liarozole fumarate (R85246): In the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer, BREAST CANC, 64(2), 2000, pp. 177-188
Authors:
Jin, TR
Zhang, XY
Li, HQ
Goss, PE
Citation: Tr. Jin et al., Characterization of a novel silencer element in the human aromatase gene PII promoter, BREAST CANC, 62(2), 2000, pp. 151-159
Authors:
Goss, PE
Oza, A
Goel, R
Nabholtz, JM
De Coster, R
Bruynseels, J
Reid, C
Wadden, N
Crump, M
Tye, LM
Citation: Pe. Goss et al., Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer, BREAST CANC, 59(1), 2000, pp. 55-68
Authors:
Suen, TC
Goss, PE
Citation: Tc. Suen et Pe. Goss, Characterization of a repressor element and a juxtaposed tissue-restrictedactivator element located on the distal neu gene promoter, J BIOL CHEM, 275(9), 2000, pp. 6600-6607
Authors:
Abraham, R
Nagy, T
Goss, PE
Crump, M
Citation: R. Abraham et al., High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases, CANCER, 88(4), 2000, pp. 790-795
Authors:
Goss, PE
Citation: Pe. Goss, Risks versus benefits in the clinical application of aromatase inhibitors, ENDOCR-R CA, 6(2), 1999, pp. 325-332
Authors:
Peng, HQ
Liu, L
Goss, PE
Bailey, D
Hogg, D
Citation: Hq. Peng et al., Chromosomal deletions occur in restricted regions of 5q in testicular germcell cancer, ONCOGENE, 18(21), 1999, pp. 3277-3283
Authors:
Goss, PE
Winer, EP
Tannock, IF
Schwartz, LH
Citation: Pe. Goss et al., Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients, J CL ONCOL, 17(1), 1999, pp. 52-63
Authors:
Gervais-Fagnou, DD
Girouard, C
Laperriere, N
Pintillie, M
Goss, PE
Citation: Dd. Gervais-fagnou et al., Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease, ONCOL-BASEL, 57(3), 1999, pp. 224-231
Authors:
Goss, PE
Walde, D
De Coster, R
Langenaeken, C
Bruynseels, J
Citation: Pe. Goss et al., Rivizor - A new third-generation aromatase inhibitor for the treatment of advanced breast cancer after tamoxifen failure, ONCOL-BASEL, 56(2), 1999, pp. 114-121
Authors:
Suen, TC
Goss, PE
Citation: Tc. Suen et Pe. Goss, Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 bi-directional promoter, J BIOL CHEM, 274(44), 1999, pp. 31297-31304
Authors:
Jin, TR
Branch, DR
Zhang, XY
Qi, SL
Youngson, B
Goss, PE
Citation: Tr. Jin et al., Examination of POU homeobox gene expression in human breast cancer cells, INT J CANC, 81(1), 1999, pp. 104-112
Authors:
Goss, PE
Reid, C
Pintilie, M
Lim, R
Miller, N
Citation: Pe. Goss et al., Male breast carcinoma - A review of 229 patients who presented to the princess margaret hospital during 40 years: 1955-1996, CANCER, 85(3), 1999, pp. 629-639
Authors:
Foulkes, WD
Brunet, JS
Warner, E
Goodwin, PJ
Meschino, W
Narod, SA
Goss, PE
Glendon, G
Citation: Wd. Foulkes et al., The importance of a family history of breast cancer in predicting the presence of a BRCA mutation, AM J HU GEN, 65(6), 1999, pp. 1776-1779
Authors:
Dawson, LA
Chow, E
Goss, PE
Citation: La. Dawson et al., Evolving perspectives in contralateral breast cancer, EUR J CANC, 34(13), 1998, pp. 2000-2009
Risultati:
1-19
|